Medication-Assisted Treatment (MAT) programs are expanding in an effort to deliver a comprehensive continuum of outpatient detoxification to support ongoing recovery.
As a result mental health & addiction recovery treatment programs have mounted a targeted response to the opioid crisis by acquiring funding that aims to address the opioid crisis by increasing access to treatment and reducing unmet treatment need. Meeting this demand will require solving the mobile transport and delivery of treatment.
For instance, one of the latest rounds of funding amounted to $20 million of private equity this month. Eleanor Health saw 4 private investors place funding. The investors were Town Hall Ventures, Echo Health Ventures, Mosaic Health Solutions and a new private equity stake from Warburg Pincus.
Funds continue to flow to evidence-based prevention, medication-assisted treatment, and recovery support services in the post COVID era. Above all, the vast majority of these funds will be used for methadone & buprenorphine maintenance in the treatment protocol. Visit here for offerings on securing controlled substances for your facility